Cancer Associated Fibroblasts (CAFs) form a major component of the tumour microenvi-ronment, they have a complex origin and execute diverse functions in tumour development and progression. As such, CAFs constitute an attractive target for novel therapeutic interventions that will aid both diagnosis and treatment of various cancers. There are, however, a few limitations in reaching successful translation of CAF targeted interventions from bench to bedside. Several approaches targeting CAFs have been investigated so far and a few CAF‐targeting tracers have suc-cessfully been developed and applied. This includes tracers targeting Fibroblast Activation Protein (FAP) on CAFs. A number of FAP‐targeting tracers have shown great promise in the clinic. In this review, we summarize our current knowledge of the functional heterogeneity and biology of CAFs in cancer. Moreover, we highlight the latest developments towards theranostic applications that will help tumour characterization, radioligand therapy and staging in cancers with a distinct CAF population.
Bibliographical noteFunding Information:
This study was funded by KWF Kankerbestrijding and the convergence health and technology grant between Erasmus MC and TU Delft.
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
- EMC OR-01